title: Successful use of ecallantide to treat a hereditary angioedema attack after failure of C1 inhibitor prophylaxis.
authors.forename: Shayna
authors.initials: S
authors.lastname: Burke
authors.forename: Andrej
authors.initials: A
authors.lastname: Petrov
authors.forename: Jonas
authors.initials: J
authors.lastname: Johnson
authors.forename: Andrew
authors.initials: A
authors.lastname: MacGinnitie
mesh_terms: D054179:Angioedemas, Hereditary / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D003174:Complement C1 Inactivator Proteins / Q000008:administration & dosage / Q000009:adverse effects; D050718:Complement C1 Inhibitor Protein; D005260:Female; D006801:Humans; D007610:Kallikreins / Q000037:antagonists & inhibitors; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D011183:Postoperative Complications; D012074:Remission Induction; D014135:Tracheal Stenosis / Q000209:etiology*; D014139:Tracheostomy; D016896:Treatment Outcome
chemical_list: D003174:Complement C1 Inactivator Proteins; D050718:Complement C1 Inhibitor Protein; D010455:Peptides; C469952:SERPING1 protein, human; C511194:ecallantide; D007610:Kallikreins